LAGUNA HILLS, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, …
A large study of genes linked to age-related macular degeneration finds 52 common and rare variants in 34 DNA locations, 16 of which have not previously been linked to the disease.
Roche announced today the commercial availability of the cobas HBVassay for use on the cobas 4800 System in countries accepting the CE mark. This new molecular diagnostic assay expands the available virology menu on the cobas 4800 System, improving sys…
FLORENCE, Italy — High-dose zinc, as in the AREDS and AREDS2 formulations, may be harmful in patients with high complement factor H and low age-related maculopathy susceptibility 2 risk alleles, according to one speaker. “There is considerable evidence that response to AREDS supplements is influenced by genetic risk,” Carl C. Awh, MD, said at the FLOREtina meeting.
(MedPage Today) — FDA adopts looser policy for men who have sex with men, continues deferral for hemophiliacs
NEW YORK–(BUSINESS WIRE)–Guardian has entered into a definitive agreement to acquire Avēsis, a leading government contract vision, dental and hearing provider